Skip to main content

Table 3 Association between pre-stroke warfarin use and collaterals

From: Pre-stroke warfarin enhancement of collateralization in acute ischemic stroke: a retrospective study

 

Poor rLMC vs. Not poor rLMC

Good rLMC vs. Not good rLMC

OR (95% CI)

P value

OR (95% CI)

P value

Unadjusted

0.21 (0.10–0.83)

0.021

2.11 (0.81–5.84)

0.125

Model 1

0.18 (0.05–0.61)

0.006

1.92 (0.66–5.62)

0.234

Model 2

0.17 (0.05–0.65)

0.009

2.12 (0.61–7.39)

0.239

Model 3

0.06 (0.01–0.37)

0.002

6.03 (0.94–38.71)

0.058

Model 4

0.07 (0.01–0.44)

0.005

4.80 (0.68–33.79)

0.115

  1. Model 1: Adjusted for age, gender, onset to door time;
  2. Model 2: Adjusted model 1 plus stroke risk factors;
  3. Model 3: Adjusted model 2 plus admission examinations, thrombus location, NIH stroke scale scores;
  4. Model 4: Adjusted model 3 plus prior medications
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us